DK0454739T3 - Fremgangsmåde til isolering af oprenset EPI protein fra en opløsning, især en fermenteringsopløsning - Google Patents

Fremgangsmåde til isolering af oprenset EPI protein fra en opløsning, især en fermenteringsopløsning

Info

Publication number
DK0454739T3
DK0454739T3 DK90902177.6T DK90902177T DK0454739T3 DK 0454739 T3 DK0454739 T3 DK 0454739T3 DK 90902177 T DK90902177 T DK 90902177T DK 0454739 T3 DK0454739 T3 DK 0454739T3
Authority
DK
Denmark
Prior art keywords
solution
pct
epi protein
fermentation
isolating purified
Prior art date
Application number
DK90902177.6T
Other languages
English (en)
Inventor
Ole Nordfang
Soren Carlsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of DK0454739T3 publication Critical patent/DK0454739T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
    • C12Q2337/10—Anilides
    • C12Q2337/12—Para-Nitroanilides p-NA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96461—Protein C (3.4.21.69)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90902177.6T 1989-01-19 1990-01-18 Fremgangsmåde til isolering af oprenset EPI protein fra en opløsning, især en fermenteringsopløsning DK0454739T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK412389A DK412389D0 (da) 1989-01-19 1989-01-19 Fremgangsmaade til udvinding af oprenset epi protein fra en fermenteringsoploesning

Publications (1)

Publication Number Publication Date
DK0454739T3 true DK0454739T3 (da) 1994-04-25

Family

ID=8130438

Family Applications (2)

Application Number Title Priority Date Filing Date
DK412389A DK412389D0 (da) 1989-01-19 1989-01-19 Fremgangsmaade til udvinding af oprenset epi protein fra en fermenteringsoploesning
DK90902177.6T DK0454739T3 (da) 1989-01-19 1990-01-18 Fremgangsmåde til isolering af oprenset EPI protein fra en opløsning, især en fermenteringsopløsning

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK412389A DK412389D0 (da) 1989-01-19 1989-01-19 Fremgangsmaade til udvinding af oprenset epi protein fra en fermenteringsoploesning

Country Status (9)

Country Link
US (1) US5219993A (da)
EP (1) EP0454739B1 (da)
JP (1) JP2896605B2 (da)
AT (1) ATE99323T1 (da)
AU (1) AU5024490A (da)
DE (1) DE69005618T2 (da)
DK (2) DK412389D0 (da)
ES (1) ES2049021T3 (da)
WO (1) WO1990008158A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378614A (en) * 1989-08-18 1995-01-03 Novo Nordisk A/S Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
HUP0501111A2 (en) 2001-10-15 2007-12-28 Chiron Corp Treatment of severe pneumonia by administration of tissue factor pathway inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices

Also Published As

Publication number Publication date
ES2049021T3 (es) 1994-04-01
AU5024490A (en) 1990-08-13
JPH05505385A (ja) 1993-08-12
WO1990008158A1 (en) 1990-07-26
DE69005618T2 (de) 1994-04-28
ATE99323T1 (de) 1994-01-15
EP0454739A1 (en) 1991-11-06
US5219993A (en) 1993-06-15
DE69005618D1 (de) 1994-02-10
EP0454739B1 (en) 1993-12-29
DK412389D0 (da) 1989-01-19
JP2896605B2 (ja) 1999-05-31

Similar Documents

Publication Publication Date Title
ES2168387T3 (es) Procedimiento de fraccionamiento de soluciones que contienen sacarosa.
ZA939621B (en) Protein named component B
DE68913152T2 (de) Kunstknochenstruktur für knochentransplantation.
DE69029854T2 (de) Umschaltverfahren für verdoppeltes atm-vermittlungssystem
DE3477156D1 (en) Spectacle frame and parts thereof
ATE68826T1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
DK386789A (da) Fermentor
DK0779896T3 (da) Ny fremgangsmåde til fremstilling af biologisk aktivt protein (TGF)
PT785950E (pt) Analogos do factor de crescimento de queratinocitos
DE69719497D1 (de) Verfahren zur proteinaufreinigung aus einer proteinhaltigen lösung
GR920300076T1 (en) 1,2-dioxetane compounds as chemiluminescent labels for organic and biological molecules
DK0454739T3 (da) Fremgangsmåde til isolering af oprenset EPI protein fra en opløsning, især en fermenteringsopløsning
PT92726A (pt) Processo de eliminacao de etanol de bebidas produzidas por fermentacao
DE69403087T2 (de) Verfahren zur herstellung von 9-(2-hydroxy)-ethoxy-guanin
AT384032B (de) Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
DK0536564T3 (da) Fremgangsmåde til fremstilling af streptolysin O, intakt streptolysin O fremstillet ved denne fremgangsmåde og dets anvendelse
DK628188A (da) Protein og fremgangsmaade til fremstilling deraf
AU590712B2 (en) Immune interferon and method for its purification
EP0342422A3 (en) Process for the preparation of 2',3'-dideoxynucleosides, and intermediates used therein
DE3784891T2 (de) Verfahren zur Isolierung von säurestabilen, biologisch aktiven Proteinen.
PT94612A (pt) Processo para a preparacao de tintas de disazo fibro-reactivas
HUT49151A (en) Process for production of biotinilated proteins
DE68909397T2 (de) Verfahren zur Steigerung des Wachstums von Hefe.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment